Cited by 254Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchAmyloidosis: Diagnosis, Treatment, Outcomes

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

ALSFRS-R score and its ratio: A useful predictor for ALS-progression

Kollewe, Katja, Mauss, Ulrike, Krampfl, Klaus, Petri, Susanne, Dengler, Reinhard, Mohammadi, Bahram·2008·Journal of the Neurological Sciences

DOI 10.1016/j.jns.2008.07.016

Open this paper in CoChat — free account

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder. To determine predictors of survival, we studied different parameters in our ALS Database including 479 patients. The effects of individual prognostic factors of survival were studied using Kaplan-Meier life table. The prognostic value of each factor of interest was expressed in terms of a hazard ratio. Survival from symptom-onset ranged from 4 months up to 11.9 years. Gender had no effect on survival in our cohort. However, age, site of onset, forced vital capacity, symptom duration and ALSFRS-R score at the first visit were independent prognostic factors in our population (log-rank p<0.01). The ratio of ALSFRS-R score between first symptom and first examination, during whole disease or within 100 days, correlates with survival time. We conclude that the ratio of ALSFRS-R score within 100 days is a useful parameter for clinical trials and daily clinical work in a tertiary ALS-clinic.

Integrity signals

Registry

Crossref · 10.1016/j.jns.2008.07.016

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,239
El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90191-0 · Cited by 2,171
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V., Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,303
Natural history of amyotrophic lateral sclerosis in a database population Validation of a scoring system and a model for survival prediction
Haverkamp, L. J., Appel, V., & Appel, S. H. (1995) · Brain · doi:10.1093/brain/118.3.707 · Cited by 697
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
文治, 木., Fujimura, C., Ishida, S., Nakajima, H., Furutama, D., Uehara, H., Shinoda, K., Sugino, M., & Hanafusa, T. (2006) · Neurology · doi:10.1212/01.wnl.0000194316.91908.8a · Cited by 568
Prognosis in amyotrophic lateral sclerosis: A population-based study
del Aguila, M. A., Longstreth, W. T., McGuire, V., Koepsell, T. D., & van Belle, G. (2003) · Neurology · doi:10.1212/01.wnl.0000049472.47709.3b · Cited by 469

Show all 38 references

Sorted by citations

Prognostic factors in ALS: A critical review
Chiò, A., Logroscino, G., Hardiman, O., Swingler, R., Mitchell, D., Beghi, E., Traynor, B. G., & On Behalf of the Eurals Consortium (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802566824 · Cited by 1,172
Regulatory T‐lymphocytes mediate amyotrophic lateral sclerosis progression and survival
Henkel-Tigges, J., Beers, D. R., Wen, S., Rivera, A. L., Toennis, K. M., Appel, J. E., Zhao, W., Moore, D. H., Powell, S. Z.-E., & Appel, S. H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201544 · Cited by 355
Lumbar Intraspinal Injection of Neural Stem Cells in Patients with Amyotrophic Lateral Sclerosis: Results of a Phase I Trial in 12 Patients
Glass, J. D., Boulis, N. M., Johe, K. K., Rutkove, S. B., Federici, T., Polak, M. A., Kelly, C. M., & Feldman, E. L. (2012) · Stem Cells · doi:10.1002/stem.1079 · Cited by 298
Hypermetabolism in ALS is associated with greater functional decline and shorter survival
Steyn, F. J., Ioannides, Z. A., van Eijk, R. P. A., Heggie, S., Thorpe, K., Ceslis, A., Heshmat, S., Henders, A. K., Wray, N. R., van den Berg, L. H., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317887 · Cited by 245
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
Mora, J. S., Genge, A. L., Chiò, A., Estol, C. J., Chaverri, D., Hernández, M., Marín, S., Cadavid, J. M., Rodriguez, G. E., Povedano, M., et al. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2019.1632346 · Cited by 233
Changes of resting state brain networks in amyotrophic lateral sclerosis
Mohammadi, B., Kollewe, K., Samii, A., Krampfl, K., Dengler, R., & Münte, T. F. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.025 · Cited by 222
Self-citation
Rate of disease progression: A prognostic biomarker in ALS
Labra, J., Menon, P., Byth, K., Morrison, S., & Vucic, S. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310998 · Cited by 209
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Küffner, R., Zach, N., Norel, R., Hawe, J. S., Schoenfeld, D., Wang, L., Li, G., Fang, L., Mackey, L. W., Hardiman, O. M., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3051 · Cited by 192
MISSING DATA IMPUTATION IN THE ELECTRONIC HEALTH RECORD USING DEEPLY LEARNED AUTOENCODERS
Beaulieu‐Jones, B. K., & Moore, J. H. (2016) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789813207813_0021 · Cited by 194
Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis
van der Burgh, H. K., Schmidt, R., Westeneng, H., de Reus, M. A., van den Berg, L. H., & van den Heuvel, M. P. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.10.008 · Cited by 191
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
Cudkowicz, M., Bozik, M. E., Ingersoll, E. W., Miller, R. G., Mitsumoto, H., Shefner, J. M., Moore, D. H., Schoenfeld, D., Mather, J. L., Archibald, D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2579 · Cited by 178
Semi-supervised learning of the electronic health record for phenotype stratification
Beaulieu‐Jones, B. K., & Greene, C. S. (2016) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2016.10.007 · Cited by 175
Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis
Franchignoni, F. P., Mora, G., Giordano, A., Volanti, P., & Chiò, A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304701 · Cited by 166
Transplantation of spinal cord–derived neural stem cells for ALS
Glass, J. D., Hertzberg, V., Boulis, N. M., Riley, J. P., Federici, T., Polak, M. A., Bordeau, J., Fournier, C. N., Johe, K. K., Hazel, T., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002889 · Cited by 160
Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis
Lunetta, C., Lizio, A., Maestri, E., Sansone, V., Mora, G., Miller, R. G., Appel, S. H., & Chiò, A. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.6179 · Cited by 126
Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis
Statland, J. M., Barohn, R. J., McVey, A., Katz, J., & Dimachkie, M. M. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.006 · Cited by 120
ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression
Quek, H., Cuní‐López, C., Stewart, R., Colletti, T., Notaro, A., Sun, Y., Guo, C. C., Lupton, M. K., Nguyen, T. H., Oikari, L. E., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02421-1 · Cited by 108
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis
Körner, S., Kollewe, K., Ilsemann, J., Müller-Heine, A., Dengler, R., Krampfl, K., & Petri, S. (2012) · European Journal of Neurology · doi:10.1111/ene.12015 · Cited by 101
Self-citation
Motor cortical function determines prognosis in sporadic ALS
Shibuya, K., Park, S. B., Geevasinga, N., Menon, P., Howells, J., Simon, N. G., Huynh, W., Noto, Y., Götz, J., Kril, J. J., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002912 · Cited by 100
Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis
Fujimura, C., Kimura, F., Ishida, S., Nakajima, H., Hosokawa, T., Sugino, M., & Hanafusa, T. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300141 · Cited by 98
The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset
Proudfoot, M., Jones, A., Talbot, K., Al‐Chalabi, A., & Turner, M. R. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2016.1140786 · Cited by 95
Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS
Chipika, R. H., Finegan, E., Shing, S. L. H., Hardiman, O. M., & Bede, P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00229 · Cited by 93
Speech Movement Measures as Markers of Bulbar Disease in Amyotrophic Lateral Sclerosis
Shellikeri, S., Green, J. R., Kulkarni, M., Rong, P., Martino, R., Zinman, L. H., & Yunusova, Y. (2016) · Journal of Speech Language and Hearing Research · doi:10.1044/2016_jslhr-s-15-0238 · Cited by 93
Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study
de la Rubia, J. E., Drehmer, E., Platero, J. L., Benlloch, M., Caplliure-Llopis, J., Villaron-Casales, C., de Bernardo, N., AlarcÓn, J., Fuente, C., Carrera, S., et al. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1536152 · Cited by 92
Online assessment of ALS functional rating scale compares well to in-clinic evaluation: A prospective trial
Maier, A., Holm, T., Wicks, P. J., Steinfurth, L., Linke, P., Münch, C., Meyer, R., & Meyer, T. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.633268 · Cited by 87
Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis
Camu, W., Tremblier, B., Plassot, C., Alphandery, S., Salsac, C., Pageot, N., Juntas-Morales, R., Scamps, F., Daures, J.-P., & Raoul, C. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.005 · Cited by 95
The diagnostic utility of patient-report and speech-language pathologists’ ratings for detecting the early onset of bulbar symptoms due to ALS
Allison, K. M., Yunusova, Y., Campbell, T. F., Wang, J., Berry, J. D., & Green, J. R. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1303515 · Cited by 87
The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review
Grolez, G., Moreau, C., Danel-Brunaud, V., Delmaire, C., Lopes, R., Pradat, P., Mendili, M. M. E., Defebvre, L., & Devos, D. (2016) · BMC Neurology · doi:10.1186/s12883-016-0672-6 · Cited by 84
Biological Markers of Mesenchymal Stromal Cells as Predictors of Response to Autologous Stem Cell Transplantation in Patients With Amyotrophic Lateral Sclerosis: An Investigator-Initiated Trial and In Vivo Study
Kim, H. Y., Kim, H., Oh, K., Oh, S., Koh, S., Baik, W., Noh, M., Kim, K. S., & Kim, S. H. (2014) · Stem Cells · doi:10.1002/stem.1770 · Cited by 83
Minimally Detectable Change and Minimal Clinically Important Difference of a Decline in Sentence Intelligibility and Speaking Rate for Individuals With Amyotrophic Lateral Sclerosis
Stipancic, K. L., Yunusova, Y., Berry, J. D., & Green, J. R. (2018) · Journal of Speech Language and Hearing Research · doi:10.1044/2018_jslhr-s-17-0366 · Cited by 83
Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS)
Fournier, C. N., Bedlack, R., Quinn, C. C., Russell, J., Beckwith, D., Kaminski, K. H., Tyor, W. R., Hertzberg, V., James, V., Polak, M. A., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4490 · Cited by 82
Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials
van Eijk, R. P. A., Eijkemans, M. J. C., Ferguson, T. A., Nikolakopoulos, S., Veldink, J. H., & van den Berg, L. H. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317077 · Cited by 81
Muscle changes in amyotrophic lateral sclerosis: A longitudinal ultrasonography study
Arts, I. M. P., Overeem, S., Pillen, S., Schelhaas, H. J., & Zwarts, M. J. (2010) · Clinical Neurophysiology · doi:10.1016/j.clinph.2010.07.023 · Cited by 79
Speech therapy and communication device: Impact on quality of life and mood in patients with amyotrophic lateral sclerosis
Körner, S., Siniawski, M., Kollewe, K., Rath, K. J., Krampfl, K., Zapf, A., Dengler, R., & Petri, S. (2012) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/17482968.2012.692382 · Cited by 77
Self-citation
RandomForest4Life: A Random Forest for predicting ALS disease progression
Hothorn, T., & Jung, H. H. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.893361 · Cited by 73
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)
Mandrioli, J., Crippa, V., Cereda, C., Bonetto, V., Zucchi, E., Gessani, A., Ceroni, M., Chiò, A., D’Amico, R., Monsurrò, M. R., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028486 · Cited by 70
Autonomic dysfunction in the early stage of ALS with bulbar involvement
Merico, A., & Cavinato, M. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.584628 · Cited by 70
Phrenic nerve studies predict survival in amyotrophic lateral sclerosis
Pinto, S., Pinto, A. C., & de Carvalho, M. A. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2012.05.012 · Cited by 70
A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements
Franchignoni, F. P., Mandrioli, J., Giordano, A., Ferro, S., & ERRALS Group (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1026829 · Cited by 68
Long-term survival analysis of masitinib in amyotrophic lateral sclerosis
Mora, J. S., Bradley, W. G., Chaverri, D., Hernández-Barral, M., Cadavid, J. M., Gámez, J., Gargiulo-Monachelli, G. M., Moussy, A., Mansfield, C. D., Hermine, O., et al. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211030365 · Cited by 68
Prognostic factors for the course of functional status of patients with ALS: a systematic review
Creemers, H., Grupstra, H. F., Nollet, F., van den Berg, L. H., & Beelen, A. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7564-8 · Cited by 63
Cross-cultural adaptation and validation of als Functional Rating Scale-Revised in Portuguese language
Guedes, K., Pereira, C., Pavan, K., & Valério, B. C. O. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000100010 · Cited by 64
Does surgery accelerate progression of amyotrophic lateral sclerosis?
Pinto, S., Swash, M., & de Carvalho, M. A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305770 · Cited by 62
Factors predicting one-year mortality in amyotrophic lateral sclerosis patients - data from a population-based registry
Wolf, J., Safer, A., Wöhrle, J. C., Palm, F., Nix, W. A., Maschke, M., & Grau, A. J. (2014) · BMC Neurology · doi:10.1186/s12883-014-0197-9 · Cited by 60
Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients
Park, Y., Park, J., Kim, Y., Baek, H., & Kim, S. H. (2015) · Nutrition · doi:10.1016/j.nut.2015.05.025 · Cited by 59
The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate
Koh, S., Baik, W., Noh, M., Cho, G. W., Kim, H., Kim, K. S., & Kim, S. H. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.021 · Cited by 58
Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach
Kueffner, R., Zach, N., Bronfeld, M., Norel, R., Atassi, N., Balagurusamy, V. S. K., Camillo, B. D., Chiò, A., Cudkowicz, M., Dillenberger, D. E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36873-4 · Cited by 56
Deep learning-based phenotype imputation on population-scale biobank data increases genetic discoveries
An, U., Pazokitoroudi, A., Alvarez, M., Huang, L., Bacanu, S., Schork, A. J., Kendler, K. S., Pajukanta, P., Flint, J., Zaitlen, N., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01558-w · Cited by 60
Muscle ultrasonography to predict survival in amyotrophic lateral sclerosis
Arts, I. M. P., Overeem, S., Pillen, S., Schelhaas, H. J., & Zwarts, M. J. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.200519 · Cited by 55
Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures
Johnson, S. A., Karas, M., Burke, K. M., Strączkiewicz, M., Scheier, Z. A., Clark, A., Iwasaki, S., Lahav, A., Iyer, A., Onnela, J.-P. “., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00778-y · Cited by 53
Lower motor neuron involvement in ALS assessed by motor unit number index (MUNIX): Long-term changes and reproducibility
Fathi, D., Mohammadi, B., Dengler, R., Böselt, S., Petri, S., & Kollewe, K. (2016) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.12.023 · Cited by 52
Self-citation
Extent of cortical involvement in amyotrophic lateral sclerosis – an analysis based on cortical thickness
Thorns, J., Jansma, H., Peschel, T., Großkreutz, J., Mohammadi, B., Dengler, R., & Münte, T. F. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-148 · Cited by 51
Self-citation
Predicting Survival of Patients with Amyotrophic Lateral Sclerosis at Presentation: A 15-Year Experience
Gordon, P. H., Salachas, F., Lacomblez, L., Forestier, N. L., Pradat, P., Bruneteau, G., Elbaz, A., & Meininger, V. (2012) · Neurodegenerative Diseases · doi:10.1159/000341316 · Cited by 51
Motor unit number index and neurophysiological index as candidate biomarkers of presymptomatic motor neuron loss in amyotrophic lateral sclerosis
Escorcio‐Bezerra, M. L., Abrahão, A., Nunes, K. F., Braga, N. I. D. O., Oliveira, A. S. B., Zinman, L. H., & Manzano, G. M. (2018) · Muscle & Nerve · doi:10.1002/mus.26087 · Cited by 51
Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis
Cheah, B. C., Lin, C. S.-Y., Park, S. B., Vucic, S., Krishnan, A. V., & Kiernan, M. C. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2012.06.020 · Cited by 49
Patients’ self‐perceived burden, caregivers’ burden and quality of life for amyotrophic lateral sclerosis patients: a cross‐sectional study
Geng, D., Ou, R., Miao, X., Zhao, L., Wei, Q., Chen, X., Liang, Y., Shang, H., & Yang, R. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13667 · Cited by 49
Structural MRI correlates of amyotrophic lateral sclerosis progression
Senda, J., Atsuta, N., Watanabe, H., Bagarinao, E., Imai, K., Yokoi, D., Riku, Y., Masuda, M., Nakamura, R., Watanabe, H., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314337 · Cited by 49
Semi-Supervised Learning of the Electronic Health Record for Phenotype StratificationPreprint
Beaulieu‐Jones, B. K., & Greene, C. S. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/039800 · Cited by 48
Evidence for peripheral immune activation in amyotrophic lateral sclerosis
Chen, X., Feng, W., Huang, R., Guo, X., Chen, Y., Zheng, Z., & Shang, H. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.09.025 · Cited by 51
Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self‐report scale (Center for Neurologic Study Bulbar Function Scale)
Smith, R. A., Macklin, E. A., Myers, K. J., Pattee, G. L., Goslin, K., Meekins, G. D., Green, J. R., Shefner, J. M., & Pioro, E. P. (2018) · European Journal of Neurology · doi:10.1111/ene.13638 · Cited by 48
Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double‐Blind, Placebo‐Controlled, Crossover Trial
Kovalchuk, M. O., Heuberger, J. A. A. C., Sleutjes, B. T. H. M., Ziagkos, D., van den Berg, L. H., Ferguson, T. A., Franssen, H., & Groeneveld, G. J. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1096 · Cited by 48
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial
Statland, J., Moore, D. H., Wang, Y., Walsh, M., Mozaffar, T., Elman, L. B., Nations, S., Mitsumoto, H., Fernandes, J. A., Saperstein, D., et al. (2018) · Muscle & Nerve · doi:10.1002/mus.26335 · Cited by 48
Sensory cortex hyperexcitability predicts short survival in amyotrophic lateral sclerosis
Shimizu, T., Bokuda, K., Kimura, H., Kamiyama, T., Nakayama, Y., Kawata, A., Isozaki, E., & Ugawa, Y. (2018) · Neurology · doi:10.1212/wnl.0000000000005424 · Cited by 47
Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction
Pfohl, S. R., Kim, R. B., Coan, G., & Mitchell, C. S. (2018) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2018.00036 · Cited by 46
Acoustic analysis of voice in bulbar amyotrophic lateral sclerosis: a systematic review and meta-analysis of studies
Chiaramonte, R., & Bonfiglio, M. (2019) · Logopedics Phoniatrics Vocology · doi:10.1080/14015439.2019.1687748 · Cited by 46
Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort
Walt, G. S., Burris, H. M., Brady, C. B., Spencer, K. R., Alvarez, V. E., Huber, B. R., Guilderson, L., Abdul Rauf, N., Collins, D., Singh, T., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly092 · Cited by 45
A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial
Shibuya, K., Misawa, S., Kimura, H., Noto, Y., Sato, Y., Sekiguchi, Y., Iwai, Y., Mitsuma, S., Beppu, M., Watanabe, K., et al. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1038277 · Cited by 45
The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients
Pirola, A., Mattia, E. D., Lizio, A., Sannicolò, G., Carraro, E., Rao, F., Sansone, V., & Lunetta, C. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.105456 · Cited by 45
Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis
Shang, H., Wei, Q., Hou, Y., Zhang, L., Ou, R., Cao, B., & Chen, Y. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.322476 · Cited by 45
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
Zach, N., Ennist, D. L., Taylor, A. A., Alon, H., Sherman, A., Kueffner, R., Walker, J., Sinani, E., Katsovskiy, I., Cudkowicz, M., et al. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0336-z · Cited by 45
Gait in amyotrophic lateral sclerosis: Is gait pattern differently affected in spinal and bulbar onset of the disease during dual task walking?
Radovanovic, S. M., Milićev, M., Perić, S., Basta, I. Z., Kostić, V., & Stević, Z. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.918148 · Cited by 43
A machine-learning based objective measure for ALS disease severity
Vieira, F. G., Venugopalan, S., Premasiri, A. S., McNally, M., Jansen, A., McCloskey, K., Brenner, M. P., & Perrin, S. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00588-8 · Cited by 51
The predictors of survival in Chinese amyotrophic lateral sclerosis patients
Wei, Q., Chen, X., Zheng, Z., Guo, X., Huang, R., Cao, B., Zeng, Y., & Shang, H. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.993650 · Cited by 42
Rate of speech decline in individuals with amyotrophic lateral sclerosis
Eshghi, M., Yunusova, Y., Connaghan, K. P., Perry, B. J., Maffei, M. F., Berry, J. D., Zinman, L. H., Kalra, S., Korngut, L. W., Genge, A. L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19651-1 · Cited by 40
Predictors of impaired communication in amyotrophic lateral sclerosis patients with tracheostomy-invasive ventilation
Nakayama, Y., Shimizu, T., Mochizuki, Y., Hayashi, K., Matsuda, C., Nagao, M., Watabe, K., Kawata, A., Oyanagi, K., Isozaki, E., et al. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1055276 · Cited by 40
Depression and disease progression in amyotrophic lateral sclerosis: A comprehensive meta-regression analysis
Pagnini, F., Manzoni, G. M., Tagliaferri, A., & Sidey-Gibbons, C. J. (2014) · Journal of Health Psychology · doi:10.1177/1359105314530453 · Cited by 39
Increased iron level in motor cortex of amyotrophic lateral sclerosis patients: An in vivo MR study
Yu, J., Qi, F., Wang, N., Gao, P., Dai, S., Lu, Y., Su, Q., Du, Y., & Che, F. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.906618 · Cited by 39
Patient-Reported Outcome of Physical Therapy in Amyotrophic Lateral Sclerosis: Observational Online Study
Meyer, R., Spittel, S., Steinfurth, L., Funke, A., Kettemann, D., Münch, C., Meyer, T., & Maier, A. (2018) · JMIR Rehabilitation and Assistive Technologies · doi:10.2196/10099 · Cited by 39
Biological follow‐up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis
Patin, F., Corcia, P., Hounoum, B. M., Veyrat‐Durebex, C., Respaud, E., Piver, É., Bretagne, I. B., Vourc’h, P., Andres, C. R., & Blasco, H. (2015) · European Journal of Neurology · doi:10.1111/ene.12754 · Cited by 37
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement
Macchi, Z. A., Wang, Y., Moore, D. H., Katz, J., Saperstein, D., Walk, D., Simpson, E. P., Genge, A. L., Bertorini, T. E., Fernandes, J. A., et al. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1026826 · Cited by 36
The Relationship between Depressive Symptoms, Disease State, and Cognition in Amyotrophic Lateral Sclerosis
Jelsone-Swain, L. M., Persad, C. C., Votruba, K., Weisenbach, S. L., Johnson, T. D., Gruis, K. L., & Welsh, R. C. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00542 · Cited by 37
Qualitative measures that assess functional disability and quality of life in ALS
Hartmaier, S. L., Rhodes, T., Cook, S. F., Schlusser, C. L., Chen, C., Han, S., Zach, N., Murthy, V., & Davé, S. (2022) · Health and Quality of Life Outcomes · doi:10.1186/s12955-022-01919-9 · Cited by 40
Factors predicting survival in amyotrophic lateral sclerosis patients on non-invasive ventilation
Calzada, N. G., Soro, E. P., Gómez, L. M., Bulta, E. G., Córdoba-Izquierdo, A., Panadés, M. P., Dorca, J., & Muñoz, E. F. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2016.1165256 · Cited by 37
Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis — Data from a population-based registry
Wolf, J., Safer, A., Wöhrle, J. C., Palm, F., Nix, W. A., Maschke, M., & Grau, A. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.07.033 · Cited by 37
Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival
Lunetta, C., Lizio, A., Melazzini, M. G., Maestri, E., & Sansone, V. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1083585 · Cited by 35
Articulatory Kinematic Characteristics Across the Dysarthria Severity Spectrum in Individuals With Amyotrophic Lateral Sclerosis
Lee, J., Bell, M., & Simmons, Z. (2017) · American Journal of Speech-Language Pathology · doi:10.1044/2017_ajslp-16-0230 · Cited by 35
Erythropoietin modulates the immune-inflammatory response of a SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS)
Noh, M., Cho, K., Kim, H., Kim, S.-M., & Kim, S. H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.05.001 · Cited by 34
Patterns of cortical activity differ in ALS patients with limb and/or bulbar involvement depending on motor tasks
Kollewe, K., Münte, T. F., Samii, A., Dengler, R., Petri, S., & Mohammadi, B. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5842-7 · Cited by 33
Self-citation
Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited
Kollewe, K., Wurster, U., Sinzenich, T., Körner, S., Dengler, R., Mohammadi, B., & Petri, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125339 · Cited by 33
Self-citation
Speech intelligibility decline in individuals with fast and slow rates of ALS progression
Rong, P., Yunusova, Y., & Green, J. R. (2015) · Interspeech (USB) · doi:10.21437/interspeech.2015-614 · Cited by 32
Plasma cortisol level in amyotrophic lateral sclerosis
Spataro, R., Volanti, P., Vitale, F. M., Meli, F., Colletti, T., Natale, A., & Bella, V. L. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.09.011 · Cited by 31
A speech measure for early stratification of fast and slow progressors of bulbar amyotrophic lateral sclerosis: lip movement jitter
Rong, P., Yunusova, Y., Eshghi, M., Rowe, H. P., & Green, J. R. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2019.1681454 · Cited by 31
CNN-based severity prediction of neurodegenerative diseases using gait data
Erdaş, Ç. B., Sümer, E., & Kibaroğlu, S. (2022) · Digital Health · doi:10.1177/20552076221075147 · Cited by 31
Prognostic models based on patient snapshots and time windows: Predicting disease progression to assisted ventilation in Amyotrophic Lateral Sclerosis
Carreiro, A. V., Amaral, P. M., Pinto, S., Tomás, P., de Carvalho, M. A., & Madeira, S. C. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.09.021 · Cited by 31
Magnetization Transfer Imaging Demonstrates a Distributed Pattern of Microstructural Changes of the Cerebral Cortex in Amyotrophic Lateral Sclerosis
Cosottini, M., Pesaresi, I., Piazza, S., Diciotti, S., Belmonte, G., Battaglini, M., Ginestroni, A., Siciliano, G., Stefano, N. D., & Mascalchi, M. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2356 · Cited by 30
VEGF levels in CSF and serum in mild ALS patients
Gao, L., Zhou, S., Cai, H., Gong, Z., & Zang, D. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.08.031 · Cited by 30
Need and value of case management in multidisciplinary ALS care: A qualitative study on the perspectives of patients, spousal caregivers and professionals
Bakker, M., Creemers, H., Schipper, K., Beelen, A., Grupstra, H. F., Nollet, F., & Abma, T. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.971811 · Cited by 30
Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: Subgroup analysis of demographic and clinical characteristics
Rudnicki, S. A., Berry, J. D., Ingersoll, E. W., Archibald, D., Cudkowicz, M., Kerr, D. A., & Dong, Y. (2012) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/17482968.2012.723723 · Cited by 29
High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial
Zucchi, E., Vinceti, M., Malagoli, C., Fini, N., Gessani, A., Fasano, A., Rizzi, R., Sette, E., Cavazza, S., Fiocchi, A., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.765 · Cited by 28
Decreased brain activation to tongue movements in amyotrophic lateral sclerosis with bulbar involvement but not Kennedy syndrome
Mohammadi, B., Kollewe, K., Samii, A., Krampfl, K., Dengler, R., & Münte, T. F. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5112-8 · Cited by 28
Self-citation

Authors: Kollewe, K., Mauss, U., Krampfl, K., Petri, S., Dengler, R., & Mohammadi, B.
Affiliations: Medizinische Hochschule Hannover (DE)
Corresponding author: Mohammadi, Bahram
ORCID: Petri, Susanne
Dengler, Reinhard
Mohammadi, Bahram
Venue: Journal of the Neurological Sciences
Publisher: Elsevier BV
Published: 2008-12
Volume: 275
Issue: 1-2
Pages: 69-73
ISSN: 0022-510X (ISSN-L)
DOI: 10.1016/j.jns.2008.07.016
OpenAlex: W2026980091
Cited by: 253
References: 38
Citations by year: 2026: 8 · 2025: 11 · 2024: 18 · 2023: 15 · 2022: 21 · 2021: 13 · 2020: 15 · 2019: 18 · 2018: 26 · 2017: 15 · 2016: 19 · 2015: 23 · 2014: 15 · 2013: 7 · 2012: 11
FWCI: 3.84
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of the Neurological Sciences (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
Keywords: amyotrophic lateral sclerosis, ALSFRS-R, disease progression, survival prediction, prognostic factors, symptom onset, age, forced vital capacity, symptom duration, hazard ratio
MeSH terms: Adult, Age Factors, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Severity of Illness Index, Cohort Studies, Age of Onset, Disease Progression, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ALSFRS-R score and its ratio: A useful predictor for ALS-progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks